HKU Surgery

【🏥✨港大醫學院於香港率先引進機械人輔助顯微外科手術
HKUMed pioneers robot-assisted microsurgery in Hong Kong】

港大外科臨床團隊，於香港率先引進機械人輔助顯微外科手術。團隊至今已成功完成48宗手術，當中包括全球首例在肝臟移植手術中採用機械人微血管吻合術，以及經髮際線機械人輔助微血管吻合術。該技術的其他應用包括腫瘤切除後的重建手術、淋巴手術和創傷手術等。臨床數據顯示，所有患者進行機械人顯微手術後均無出現併發症，且吻合口均保持通暢。
港大外科臨床副教授兼瑪麗醫院頭頸及整形修復外科主管周令宇教授表示，機械人系統能提供更高的穩定性、精準度與控制力，即使在極嚴苛的條件下，外科醫生仍能有效進行操作。同時，系統令學習過程更為直觀且具可重複性，有助更短時間內培訓出高水平的外科醫生。
港大外科臨床教授、李樹芬醫學基金會教授席（外科）兼瑪麗醫院肝臟移植中心總監陳智仁教授指出，我們在全球率先將機械人輔助顯微外科技術應用於肝臟移植，為該領域樹立新標竿。
這項突破性進展不僅彰顯港大醫學院與瑪麗醫院在推動精準外科手術方面的領導地位，更為全球複雜外科手術護理設定全新標準，港大外科期望更多患者能從這項頂尖的手術中受惠。

A research team from the Department of Surgery, HKUMed has introduced robot-assisted microsurgery in Hong Kong for the first time. The team successfully completed 48 procedures, including the world's first robot-assisted liver transplant surgery and trans-hairline robotic microvascular surgery. Other applications of this technique include reconstructive procedures after tumour extirpation, lymphatic surgery and trauma surgery. Clinical data indicate no complications related to the use of the robotic micro-surgical platform. All anastomoses were patent with no long-term complications.
Professor Velda Chow, Clinical Associate Professor, Department of Surgery, HKUMed; and Division Chief, Divisions of Head and Neck Surgery and Plastic and Reconstructive Surgery at QMH, said that by delivering greater stability, precision and control, the robotic platform enables surgeons to operate effectively even under highly demanding conditions, while also making the learning experience more intuitive and reproducible. This allows us to elevate more surgeons to a high level of competency in a shorter timeframe.
Professor Albert Chan, Clinical Professor, Li Shu Fan Medical Foundation Professor in Surgery, Department of Surgery, HKUMed; and Director of the Liver Transplant Centre at QMH, remarked that our world-first application of robotic microsurgery in liver transplantation has set a new benchmark in the field.
This breakthrough highlights the leadership of HKUMed and Queen Mary Hospital (QMH) in advancing precision surgery and setting new global benchmarks in complex surgical care. The Department of Surgery hopes more patients can benefit from this cutting-edge surgical procedure.

了解更多 Learn more 🔗
https://www.med.hku.hk/en/news/press/20260624-hkumed-pioneers-robot-assisted-microsurgery-in-hong-kong

【Testosterone & Prostate Cancer Management】

Exploring men’s health on RTHK 📻.

Dr. Thomas Wong of the Department of Surgery, HKUMed, recently joined RTHK’s 精靈一點 to discuss the role of testosterone in men’s health, along with current approaches to prostate cancer management and treatment.

🎥 Watch the episode: https://www.rthk.hk/tv/dtt31/programme/healthpedia_tv/episode/1103059

Source: RTHK31

#精靈一點

【🌍 Hong Kong International Head and Neck Conference 2026】

The Hong Kong International Head and Neck Conference 2026 was successfully held on 12–13 June 2026, bringing together a vibrant international community of surgeons, oncologists, and allied health professionals united in advancing head and neck care. 🤝✨

This year’s Conference spotlighted innovation in practice and collaboration in action. A key highlight was the William I. Wei Lecture, delivered by Professor Floyd Christopher Holsinger (Stanford University School of Medicine), who shared inspiring insights on “Surgical Innovation and Evidence: Transforming Head & Neck Surgical Care with Robotics and Clinical Trials.” 🤖📊 His lecture underscored the growing impact of technology and evidence-based approaches in shaping the future of our field.

Building on this theme, the scientific programme featured interactive panel sessions and round-table case discussions, fostering dynamic exchange on current challenges and emerging solutions across key areas, including Oropharynx, Nasopharynx, Thyroid, and Innovations. 💡🗣️

Ahead of the main conference, participants took part in an immersive “Live Surgery & Movies Day” 🎬🔬, offering a front-row view of contemporary robotic techniques. Professor Holsinger’s live robotic oropharyngeal surgery, together with expert-led demonstrations, provided invaluable insights, highlighting not only technical excellence but also critical decision-making, as well as practical pearls and pitfalls from experienced surgeons.

More than a scientific meeting, this year’s Conference served as a platform for meaningful connections, knowledge exchange, and inspiration for future innovation. 🚀 We look forward to continuing this shared journey in advancing patient care and surgical excellence.

Revisit the event: https://www.surgery.hku.hk/en/About-Us/Photo-Gallery/Events-and-Workshops/Conferences-and-Workshops/Hong-Kong-International-Head-and-Neck-Conference-2026/Conference

Warmest congratulations to Professor Ian Wong on his distinguished appointment to the International Editorial Board of JAMA Surgery, effective 15 April 2026. He joins Professor Stephen Cheng, who is also currently serving on the Board, further reflecting the strong representation and leadership of our Department at the international level.

💬 Editorial: Ian Y. H. Wong, MBBS, MS, has joined the International Editorial Board of JAMA Surgery, effective April 15, 2026.

Dr Wong is a clinical associate professor at The University of Hong Kong and honorary consultant at Queen Mary Hospital, with clinical expertise in esophageal cancer and benign foregut disorders.

His leadership in multidisciplinary care includes founding the Asian Pacific Foregut Society to advance collaborative management in digestive health.

https://ja.ma/4fWCmST

【11th Vascular Innovation Symposium (VINNOVA 2026)🌐🩺】

The Division of Vascular Surgery participated in the 11th Vascular Innovation Symposium (VINNOVA 2026), held in Beijing from 22–24 May 2026.

Professor Stephen Cheng chaired a seminar session titled “Chinese Solution and Global Innovations” on endovascular aortic repair, and delivered a presentation on “Initial Clinical Results of a Novel Arch Branched Endograft.”

The symposium brought together hundreds of leading regional and international experts in vascular surgery to exchange insights on cutting-edge techniques in clinical practice, while highlighting China’s rapid advancements and innovations in graft development 🚀🔬.

【🤖 Exploring the future of surgery through learning and innovation】

HKU Surgery recently had the opportunity to explore a brand new robotic-assisted surgery system, featuring modular arm carts and an open-console design. Participants of the workshop gained new perspectives on how RAS is transforming surgical practice and training.

The session included hands-on experience with live porcine model procedures, allowing participants to engage with the platform in a realistic surgical environment and gain meaningful, practice-based insights into its capabilities.
Importantly, this opportunity extended beyond demonstration. We organised a tailored hands-on session for our surgical assistant interns during their rotation, where they stepped into the role of robotic surgeons. This immersive experience provided early exposure to advanced surgical techniques and represents a valuable milestone in preparing for the evolving landscape of surgical practice. 🎓🖥️

At HKU Surgery, we are committed to fostering a culture of innovation in surgical education—embracing emerging technologies while continuing to invest in the growth and development of future surgical leaders. 🌟👩‍⚕️👨‍⚕️

【🎉 Join Us at the Inaugural HKU Urology Congress】

We are delighted to present the Inaugural HKU Urology Congress: Focal Therapy and Fusion Biopsy for Prostate Cancer, taking place on 1 August 2026.

As the first urology congress organized by our department, this landmark event will bring together leading experts in the field to share the latest advancements in focal therapy and fusion biopsy for prostate cancer.

🔍 Programme Highlights:
• Lectures by experts on IRE, HIFU, microwave ablation for prostate cancer.
• Semi-live surgery and discussions.
• Hands-on experience with the latest prostate focal therapy and fusion biopsy tools

📌 Register Early
Scan the QR code or secure your place via the link below before 30 July 2026:
👉 https://hkuems1.hku.hk/hkuems/ec_hdetail.aspx?guest=Y&ueid=106887

We look forward to welcoming you to this exciting milestone in urology education and innovation.

【HKU Robotic Kidney Cancer Surgery Masterclass 2026】

We are pleased to share that the HKU Robotic Kidney Cancer Surgery Masterclass 2026 was held successfully today, 30 May 2026, under the Department of Surgery, HKUMed.

We were honored to have distinguished speakers including Dr. Brian Sze-Ho Ho, Dr. Cheung-Hing Cheng, Dr. Wai-Kit Ma, Dr. Chang-Chung Ngo, Dr. Simon Hoi-Lung Wong, Professor Pengfei Shao and Dr. Ketan Badani who shared valuable insights on the latest advances in robotic-assisted partial nephrectomy, including innovation, 3D image reconstruction and virtual modelling, management of renal hilar tumors, non-clamping and clampless-sutureless techniques, the evolution of partial nephrectomy, and retroperitoneal single-port surgery.

Our sincere thanks to all speakers and participants for making this event a success. We look forward to future collaboration and continued academic exchange in advancing robotic kidney cancer surgery together.

【WATA2026 First Annual Conference🌍】

The 2026 World Ablative Therapies Association (WATA) First Annual Conference was successfully held in Beijing last week, bringing together global experts to exchange insights and shape the future of ablative therapies worldwide. 🔬✨

Professor Ava Kwong represented The University of Hong Kong, delivering an invited talk on “Application of Cryoablation in Early Breast Cancer and Palliative Setting”. 🧊 The conference provided a valuable platform for knowledge exchange with leading experts, including Professor Shui Wang (Nanjing Medical University) and Professor Michael Douek (University of Oxford). 🤝

As the first and only centre in Hong Kong performing cryoablation for breast cancer, we remain committed to advancing clinical application and research in this emerging field, supported by the Health and Medical Research Fund (HMRF). Our goal is to continually enhance patient care through innovation and evidence-based practice.